Knight Therapeutics Inc. (KHTRF)

Knight Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	60.81	58.76	71.68	85.96	229.59	169.27
Short-Term Investments	96.66	95.66	85.83	63.54	147.32	238.49
Trading Asset Securities	-	15.45	28.11	10.65	29.15	6.54
Cash & Short-Term Investments	157.47	169.87	185.61	160.16	406.05	414.3
Cash Growth	4.95%	-8.48%	15.89%	-60.56%	-1.99%	-40.49%
Accounts Receivable	84.98	88.72	94.89	55.39	62.52	85.85
Other Receivables	9.92	9.51	13.68	12.03	19.53	25.89
Receivables	94.9	98.23	114	69.96	87.15	125.17
Inventory	103.65	91.83	92.49	72.4	56.51	70.87
Prepaid Expenses	4.6	4.88	3.34	2.17	2.21	3.31
Restricted Cash	-	-	-	-	-	5
Other Current Assets	-	0.3	0.18	0.29	0.18	2.88
Total Current Assets	360.61	365.12	395.62	304.97	552.1	621.52
Property, Plant & Equipment	21.49	17.86	22.63	29.94	26.16	29.05
Long-Term Investments	110.93	116.36	152.33	174.23	169.79	241.13
Goodwill	84.6	79.84	82.27	75.4	77.73	88.26
Other Intangible Assets	295.55	289.96	338.78	350.3	156.55	173.37
Long-Term Accounts Receivable	-	-	-	-	-	4.72
Long-Term Deferred Tax Assets	20.51	19.39	9.31	2.05	2.43	3.99
Other Long-Term Assets	51.68	53.3	50.13	51.28	51.18	126.13
Total Assets	945.36	945.49	1,055	991.89	1,040	1,305
Accounts Payable	77.81	85.37	106.06	65.31	44.51	72.83
Accrued Expenses	-	-	-	-	-	21.58
Short-Term Debt	-	0.61	1.61	9.19	10.11	-
Current Portion of Long-Term Debt	16.99	17.24	16.06	17.48	41.66	50.56
Current Portion of Leases	2.57	1.73	2.58	1.61	1.88	1.79
Current Income Taxes Payable	0.92	1.18	2.27	7.07	13.56	15.45
Other Current Liabilities	7.55	7.9	12.73	4.64	2.34	188.61
Total Current Liabilities	105.83	114.03	141.32	105.3	114.06	350.8
Long-Term Debt	33.96	44.02	52.4	9.27	-	5.02
Long-Term Leases	4.59	5.5	5.05	3.42	2.54	4.81
Long-Term Deferred Tax Liabilities	4.95	2.82	4.37	12.37	21.62	27.86
Other Long-Term Liabilities	33.24	32.26	25.85	19.52	15.22	1.7
Total Liabilities	182.56	198.62	228.98	149.87	153.44	390.2
Common Stock	540.95	540.05	599.06	628.85	694.35	723.83
Additional Paid-In Capital	25.66	25.99	23.66	21.78	18.73	16.46
Retained Earnings	144.26	150.89	161.76	191.65	174.55	52.25
Comprehensive Income & Other	51.94	29.95	41.38	-0.26	-1.39	18.19
Total Common Equity	762.8	746.87	825.86	842.02	886.24	810.73
Minority Interest	-	-	-	-	-	104.38
Shareholders' Equity	762.8	746.87	825.86	842.02	886.24	915.11
Total Liabilities & Equity	945.36	945.49	1,055	991.89	1,040	1,305
Total Debt	58.11	69.09	77.7	40.96	56.19	62.18
Net Cash (Debt)	103.19	108.18	123.08	119.2	365.18	478.99
Net Cash Growth	32.02%	-12.10%	3.26%	-67.36%	-23.76%	-39.63%
Net Cash Per Share	1.00	1.01	1.07	0.96	2.77	3.42
Filing Date Shares Outstanding	101.21	101.17	110.13	117.03	128.76	135.38
Total Common Shares Outstanding	101.33	101.17	112.21	117.78	130.04	135.64
Working Capital	254.78	251.09	254.3	199.67	438.04	270.72
Book Value Per Share	7.53	7.38	7.36	7.15	6.82	5.98
Tangible Book Value	382.65	377.07	404.8	416.32	651.97	549.1
Tangible Book Value Per Share	3.78	3.73	3.61	3.53	5.01	4.05
Land	-	0.93	1.55	1.09	0.89	0.96
Buildings	-	9.84	14.56	7.69	6.3	6.38
Machinery	-	21.91	33.13	25.94	18.16	15.01

Source: S&P Capital IQ. Standard template. Financial Sources.